Clinical Trial Update: Flavopiridol in Treating Patients With Refractory Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study of flavopiridol in patients with refractory cancers, including lymphoma, prostate cancer, small intestine …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Prostate Cancer
• Small Intestine Cancer
• Unspecified Adult Solid Tumor

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Prostate Cancer | Phase 1 | Status: COMPLETED